Please use this identifier to cite or link to this item:
http://hdl.handle.net/2080/3392
Title: | Dose-Dependent Paradoxical Effect of Multi-Wall Carbon Nanotube on Hepatocyte |
Authors: | Ansari, Aafreen Bharti, Deepti Rathnam, V Shanmuga Sharan Banerjee, Indranil |
Keywords: | Dose-Dependent Paradoxical Effect Multi-Wall Carbon Nanotube Hepatocyte |
Issue Date: | Nov-2019 |
Citation: | International Conference on Biomaterial -Based Therapeutic Engineering and Regenerative Medicine (BIOTERM 2019) Kanpur, India, 28 November - 01 December2019 |
Abstract: | Biomedical applications of carbon nanotubes often faced serious criticism because of its nanotoxicity. Its been observed that CNT showed hepatotoxicity in vitro at the concentration above 20µg/ml but its effect on liver cells at lower concentrations is not yet explored. Here, we performed a detailed study to evaluate the dose-dependent response of hepatocytes against CNT. For this purpose hepatocytes cell line (HepG2) were treated with multi-wall CNT (MWCNT) of different concentration ranging 100µg/ml to 10ng/ml. MWCNT at a concentration of 100µg/ml showed hepatotoxicity but at lower concentrations, it stimulate cell proliferation. LDH assay revealed that MWCNT at higher concentration caused significant damage to the cell membrane but at lower concentration, it fails to do so. It was observed that MWCNT at lower concentration increases production of albumin, ATP7B and SULT2A1. Density of bile canaliculi in HepG2 cells also increased after treatment. These studies altogether suggest that although MWCNT showed hepatotoxicity at higher concentration, it can work as a mitogen at a lower concentration. |
Description: | Copyright of this document belongs to proceedings publisher. |
URI: | http://hdl.handle.net/2080/3392 |
Appears in Collections: | Conference Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2019_BIOTERM_AAnsari_DoseDependent.pdf | Presentation | 1.91 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.